KPNA5 Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population with targeted disruption of the KPNA5 gene. This heterogeneous pool of HAP1 cells carries diverse CRISPR-induced alleles that collectively abolish KPNA5 expression, providing a versatile loss-of-function model without single-cell clonal selection.
The parental HAP1 cell line originates from the KBM-7 chronic myeloid leukemia (CML) line and exhibits a near-haploid karyotype. HAP1 cells are adherent, fibroblast-like, and maintain a largely haploid genome, which minimizes functional redundancy and facilitates unambiguous genotype?Cphenotype correlations. The CML background offers a context for oncogenic signaling studies.
KPNA5 encodes importin subunit alpha-5, a key adaptor in the classical nuclear import pathway. It binds to classical nuclear localization signals (NLS) on cargo proteins, subsequently recruiting KPNB1 (importin beta) to form a transport complex. This complex docks at the nuclear pore complex through interactions with nucleoporins such as NUP62 and NUP98, with RANBP2 (NUP358) providing an initial cytoplasmic docking site. Upon translocation into the nucleus, the small GTPase RAN in its GTP-bound form binds to KPNB1, triggering a conformational change that releases the cargo. The importin alpha/beta complex is then recycled back to the cytoplasm with assistance from RANBP1 and RANBP2. KPNA5 thus mediates the nuclear import of a diverse set of NLS-containing proteins, including transcription factors, kinases, and viral components. Key interacting partners include KPNB1, RAN, RANBP1, RANBP2, and nucleoporins. The expression of importin alpha genes is subject to cell cycle-dependent regulation, linking nuclear transport capacity to proliferation states.
In the HAP1 near-haploid background, disruption of KPNA5 creates an unambiguous loss-of-function model. The absence of a second functional allele ensures that knockout phenotypes are not masked, allowing clear assessment of how KPNA5 deficiency alters the subcellular distribution of specific cargo proteins. This is particularly valuable for distinguishing KPNA5-dependent transport from import mediated by other importin alpha family members. As HAP1 cells originate from a CML line, they retain leukemogenic signaling features, making the knockout applicable to studies of how perturbed nucleocytoplasmic transport influences cancer cell behavior. Potential impacts include mislocalization of cell cycle regulators and transcription factors, with consequences for proliferation, apoptosis, and drug responsiveness. Additionally, the model is well suited for examining viral replication cycles that hijack KPNA5 for nuclear entry of viral genomes or proteins.
This polyclonal knockout model is suited for diverse applications: western blotting confirms KPNA5 ablation; immunofluorescence visualizes cargo mislocalization; co-immunoprecipitation evaluates disrupted interactions; and RNA-seq reveals transcriptomic consequences. Functional assays can probe viral infection (e.g., influenza, HIV), cancer cell proliferation, and drug sensitivity. It also serves as a platform for screening nuclear import inhibitors. For further information, please contact Ascent Research.
